Home/Filings/4/0001127602-22-020590
4//SEC Filing

Finke Daniel P 4

Accession 0001127602-22-020590

CIK 0000064803other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 4:48 PM ET

Size

15.4 KB

Accession

0001127602-22-020590

Insider Transaction Report

Form 4
Period: 2022-08-03
Finke Daniel P
EVP/Pres, Health Care Benefits
Transactions
  • Exercise/Conversion

    Common Stock

    2022-08-03$52.37/sh+9,546$499,92441,695.961 total
  • Sale

    Common Stock

    2022-08-03$100.00/sh9,546$954,60032,149.961 total
  • Exercise/Conversion

    Stock Option

    2022-08-039,54619,094 total
    Exercise: $52.37From: 2022-05-31Exp: 2029-05-31Common Stock (9,546 underlying)
Holdings
  • Common Stock (pep)

    3,115.464
  • Stock Unit (deferred)

    3,115.464
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (27,166 underlying)
    27,166
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (51,975 underlying)
    51,975
  • Common Stock (restricted)

    15,904
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (16,161 underlying)
    16,161
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (82,066 underlying)
    82,066
Footnotes (6)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F2]Option became exercisable in three equal annual installments, commencing 5/31/2022.
  • [F3]Option became exercisable in four equal annual installments, beginning on 4/1/2020.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2022.
  • [F6]Option becomes exercisable in four equal annual installments, commencing 4/1/2023.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001844305

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:48 PM ET
Size
15.4 KB